国际肝病-专题

热点聚焦

专题首页 » 热点聚焦

[APASL前沿]鲁凤民教授团队发现血清HBV RNA可反映肝内cccDNA活性 2017-02-22
[APASL丙肝专栏]提高中国大陆丙型肝炎治疗的可及性 2017-02-17
[APASL丙肝专栏]丙型肝炎疾病负担 2017-02-16
钠-葡萄糖协同转运蛋白2抑制剂防治肝纤维化和肝癌 2016-05-31
体外扩增CD34+细胞可以治疗肝硬化 2016-05-31
肝癌诊疗新工具ARCHTECT PIVKA-II 2016-03-03
New Endpoints in HBV Drug Development 2016-03-02
Portal Vein Thrombosis in Cirrhotic and Non-cirrhotic Liver 2016-03-02
New Drugs to Overwhelm the Barriers to Eliminate HCV 2016-03-02
Welcome Message——Jinlin Hou 2016-03-02
AARC-ACLF, the Better Prognostic Score—AARC-ACLF Score predicts 30-day survival better than CLIF-SOFA 2016-03-02
LDV/SOF Efficacious in HCV Patients with Decompensated Cirrhosis 2016-03-02
VEL/SOF Effective in HCV Patients with Decompensated Cirrhosis 2016-03-02
Radiofrequency Ablation (RFA) Know-How in 2 Days — Juntendo University radiofrequency ablation (RFA) training program 2016-03-02
REP2139-Ca, a Promising NAP to Treat HBV 2016-03-02
At 38 years, just Young and Robust—25th APASL Opening Ceremony 2016-03-02
For HBV/HCV Co-infection Patients in DAA Era, Treat the Viruses both! 2016-03-02
Hepatitis B Treatment: Yesterday, Today and Tomorrow 2016-03-02
The Situation of Liver Diseases in Asian-Pacific countries and the Urgent Tasks for Beating HCV and HBV 2016-03-01
New Threat to Developed Countries: NAFLD Related HCC 2016-03-01

首页上一页 2 3 4 5 6 下一页尾页